4th Quarter - Amendment
340B HEALTH for 340B HEALTH
Firm
Client
Income
—
Expenses
$243,029
Expense method
A: Lobbying Disclosure Act definitions
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report | Jan 17, 2020 | $243,029 | Replaced |
| 4th Quarter - Amendment (this page) | Apr 21, 2020 | $243,029 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
The 340B Drug Pricing Program; FY 2020 L-HHS Appropriations, S. 1895, Lower Health Care Costs Act, H.R. 3, Lower Drug Costs Now Act of 2019, S. 2543, Prescription Drug Pricing Reduction Act (PDPRA) of 2019.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELISE CRANSTON | — |
| KATHRYN DIBITETTO | — |
| GREG DOGGETT | — |
| AMANDA SELLERS SMITH | — |
| MAUREEN TESTONI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.